Your Clinical Trial Has Competitors and Here's How to Stand Out

A clinical trial and a product launch have a lot in common. Both start with months or even years of design development, data collection, and optimization. And in both cases, consumers have options. A consumer product rarely goes into the market unopposed, and the same is true in healthcare. There are many approved drugs that typically serve as the first lines of treatment. And if a clinical trial is considered, there are thousands of trials running at any given time, so patients may have more than one available to them.

The one key difference? Every new consumer product has a defined value proposition, whereas that analysis is often lacking for a new clinical trial.

Before developing any tactics or promotional plan, the first step in creating an effective patient recruitment strategy is understanding the patient experience. In a protocol, eligibility criteria are carefully constructed. Visit schedules are negotiated between scientific necessity and practical constraint. Endpoints are chosen with statistical rigor. But what does all that mean for patients?

Planning the patient recruitment campaign from a product marketing perspective means asking questions like: Who is the customer? What problem does this solve for them/how does it potentially benefit them? What does the experience look and feel like? What are the barriers? This provides a foundation that will influence all steps after it: branding and messaging strategies, digital marketing, and more.

Understanding What You’re Selling: The Questions Every Clinical Trial Participant Is Asking

When patients are considering enrolling in a clinical trial, they are asking these 4 questions:

Am I eligible? Eligibility is often the first filter. As such, it’s important to strike a fine balance of choosing the most relevant criteria for a clinical trial and criteria that an everyday person can easily understand. Most patients wouldn’t know their eGFR measurement, but they would know what medications they’ve been prescribed or what surgeries they’ve had.

What will this actually involve? Patients deserve an honest picture of participation — visits, procedures, time commitments, and risks. Patient recruitment messaging that glosses over the most inconvenient parts is not only ethically problematic, but also counterproductive. Patients who feel unprepared for the clinical trial’s requirements may drop out early, and a dropout is far more costly than a slower enrollment curve.

How much time is required if I participate? The study visits and procedures aren’t the only burden. The aggregate time, travel, and missed work a clinical trial requires is consistently underestimated in recruitment planning. Ten visits to a retired 65-year-old looks very different than 10 visits to a working single parent. Details like how long study visits are, what they involve, and what flexibility is offered can be the deciding factor.

What's in it for me? This can be a difficult question to answer – there is no promised benefit from a clinical trial, and always a risk of adverse events. But, ignoring it doesn't make it go away. Patients weighing trial participation are making a real cost-benefit calculation. That calculation includes access to investigational treatments, close medical monitoring, compensation for time and travel, and the less tangible but genuinely meaningful sense of contributing to something larger than their own care. A strong value proposition acknowledges this and positions the trial accordingly.

Barriers to study participation in a protocol aren't design flaws to be hidden — they're strategic information. Understanding where a patient is likely to hesitate, drop off, or disengage allows the messaging to address those moments directly, rather than being blindsided by them in screening calls or site visits.

Understanding Who You’re Selling to: Clinical Trial Recruitment Starts With Knowing Your Patients

Understanding what the study involves is only the first step. Equally as important to developing an effective value proposition is understanding the patient population you’re trying to reach. For example, presenting a trial to patients who have approved treatment options is a fundamentally different challenge than recruiting patients who have none.

A patient's age, disease, treatment history, and where they are in their journey all shape how they receive your message. A newly diagnosed patient approaching a trial with hope responds differently than a third-line cancer patient who is exhausted and skeptical. Someone who has been living with a chronic condition for a decade has different motivations than someone who received their diagnosis last month. These distinctions are the raw material of your value proposition.

Developing that value proposition means asking: given everything this protocol asks of this specific patient, why would they say yes? The answer won't be the same across indications, or even across patient segments within the same trial. Getting it right requires moving beyond the diagnosis and understanding the circumstances and priorities of the patients.

The Pre-Campaign Clinical Trial Patient Recruitment Checklist

Consider questions like these during a protocol analysis. If any of these questions can't be answered confidently, those gaps may surface later — in low screening rates, high dropout, or a patient recruitment campaign that simply doesn't connect.

• Can we clearly state the value proposition in one sentence?
• Have we mapped every burden we're placing on the study participant?
• Have we identified the top three reasons a qualified patient would say no?
• Do we know what motivates this patient population specifically?
• Have we pressure-tested the visit schedule against a patient's actual life?

Start Your Clinical Recruitment Strategy Right

In the pressure of a clinical trial launch, the step of protocol analysis is often treated as a deliverable — something to check off before moving on to the "real" work of media planning, toolkit development, and site activation. That's a costly mistake.

Every downstream element of a patient recruitment campaign flows from the quality of this initial analysis. Targeting decisions depend on understanding who the ideal patient is. Not just their diagnosis, but their circumstances, motivations, and likely hesitations. Strong messaging depends on knowing which aspects of the protocol resonate and which create resistance. Prescreening tools depend on a clear, patient-friendly articulation of eligibility. Retention strategies depend on an accurate accounting of what study participation demands.

When this foundational work is done well, the rest of the campaign has something to build on. Messaging feels more specific. Patients who respond are more likely to qualify. Sites see better-prepared, more motivated participants. Conversion rates improve not because the funnel has been widened, but because the patients moving through it are the right ones.

No brand launches blind, and clinical trial sponsors shouldn't either.

‍